chemrxiv.org
Going nuclear: Improved antisense oligonucleotide activity through conjugation with a nuclear importer
Antisense oligonucleotides (ASOs) are a promising class of therapeutics designed to modulate gene expression. Both key mechanisms of action for ASOs operate in the nucleus: splice-switching ASOs modif...